Hooke Bio is pleased to announce that we will be attending the 10th CAR-TCR Summit in Boston, bringing together leaders from across the cell therapy sector to discuss the latest advances in CAR-T, TCR and next-generation immune cell therapies.
Our team will be showcasing how the Mera™ Microphysiological System is helping researchers generate more predictive, human-relevant preclinical data. Mera combines 3D tissue models with dynamic flow to recreate physiologically relevant environments, enabling the assessment of immune cell infiltration, tumour killing, cytokine release, efficacy and safety within a single integrated platform.
If you’re attending the summit, we’d love the opportunity to meet with you to discuss your research and explore how Hooke Bio and the Mera™ platform can help accelerate the development of your next-generation cell therapies.
Come and meet our team in Boston—we look forward to seeing you there!
